Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin prophylaxis after cord blood allogeneic stem cell transplantation
2013-000103-16Phase 2Active
- Sponsor
- CHU de Nantes
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of micafungin in invasive mycoses, sponsored by CHU de Nantes. Primary endpoint: Safety of micafungin prophylaxis. Started Sep 2015; status: active.
02
Drugs
micafungin
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on 2013-000103-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000103-16.